Observational register of adults with diabetes and endocrine/metabolic disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a monocentric observational registry that combines retrospective and prospective data from outpatient visits and a diabetes day hospital. It aims to identify anthropometric, clinical, laboratory, and instrumental markers associated with disease severity and activity. No extra procedures or experimental treatments are involved beyond usual clinical care. Data will come from normally collected patient information during routine diabetes care and hospital visits. Participation requires informed consent and is limited to adults of the diabetes unit who meet the eligibility criteria.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years
* Outpatient Diabetes Unit patient
* Ability to give informed consent

Diagnosis of at least one of the following:

* Metabolic disease, defined as BMI ≥25 Kg/m2
* Type 1 or type 2 diabetes mellitus
* Gestational diabetes
* Monogenic diabetes (MODY)
* Other types of diabetes or dysglycemia
* Dyslipidemia
* Arterial hypertension
* Steatosis liver disease (SLD)

Exclusion Criteria:

* Age \<18 years
* Deny participation at the study
* Recruitment in an interventional protocol
* Patients with missing significant data

Where it's running

• Diabetology Department, San Raffaele Scientific Institute
  Milan, Italy, Italy Recruiting

Study contacts

• Study coordinator: EMANUELA SETOLA, MD, PhD
• Email: setola.emanuela@hsr.it
• Phone: +390226432819

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Polypill Approach for Multiple Cardiovascular Risk Factors

  Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.

  Recruiting at 5 sites China Medical University, China · Zhengzhou, Henan and 14 other locations · NCT07679828

• Heart, kidney, and metabolic health in Shanghai community residents

  This follow-up will track people from the STONE cohort to see if changes in metabolic risk factors over time relate to heart and kidney outcomes.

  Recruiting Shanghai Changzheng Hospital · Shanghai, Shanghai Municipality · NCT07043166

• Using wearable devices to improve health in high-risk stroke patients

  This study is testing if smart wearable devices can help high-risk stroke patients manage their health better by reminding them to take medication, monitor their heart rate, and encourage exercise.

  Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT06935513

• Program to prevent young onset diabetes using genetic and clinical assessments

  This study is testing a program that uses genetic and health checks to help young adults at risk of diabetes prevent the disease and learn more about their health.

  Recruiting Asia Diabetes Foundation · Hong Kong · NCT06693934

• Examining how metabolism relates to body composition and size

  This study is testing how metabolism connects to body size and composition in both healthy people and those with metabolic disorders to see if more accurate measurements can improve our understanding.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT05398783

• Observational study of achieving LDL targets with Rovazet tablets in dyslipidemia

  This study follows patients with dyslipidemia who are prescribed Rovazet to see how well reaching LDL targets works in routine care over 48 weeks.

  Recruiting HK inno.N Corporation · Seoul · NCT07924345

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.